VOLITIONRX LTD can treat all ATM Agreement sales as permitted transactions, including amounts above the $10 million annual limit, under Lind’s September 2, 2026 waiver. The change allows excess sales without specified default remedies or anti-dilution adjustments, including price adjustments tied to sales after August 28, 2026.

Key Highlights

  • VolitionRx’s financing arrangements with Lind include a senior secured convertible Promissory Note originally issued at $7,500,000.
  • The related warrants are exercisable for up to 651,042 shares and 350,018 shares of common stock.
  • Lind’s Waiver is dated September 2, 2026, covering specified past and future ATM Agreement sales.

VOLITIONRX LTD (AMEX: VNRX) can treat all sales under its ATM Agreement as permitted transactions, including amounts above $10 million in any calendar year. Lind’s consent became effective September 2, 2026. The waiver covers past and future sales, removes specified default remedies tied to those transactions and waives anti-dilution adjustments for sales after August 28, 2026.

$10M ATM Permission

VolitionRx and Lind entered into a Securities Purchase Agreement on May 15, 2025, later amended and restated on January 7, 2026. Under that agreement, VolitionRx issued Lind a senior secured convertible promissory note with an original principal amount of $7,500,000 and a second note with an original principal amount of $2,400,000. The financing also includes a 2025 Warrant exercisable for up to 651,042 shares of common stock and another warrant exercisable for up to 350,018 shares. The common stock has a Par Value of $0.001 per share.

Lind Waives Default Remedies

The consent applies to sales made before and after the waiver’s effective date. The waiver covers remedies connected with the prohibited-transactions and event-of-default provisions in the Purchase Agreement and the Notes. Lind also waived rights that could otherwise include declaring amounts due, demanding immediate payment in full, accelerating obligations, increasing obligations or foreclosing on collateral, but only when those rights were triggered by ATM Agreement sales. The agreement also covers existing and future covenant-breach events of default arising from ATM Agreement sales.

Conversion Price Protection Waived

The waiver applies across the Notes and Warrants. The Conversion Price and Exercise Price were adjusted under their respective terms for ATM Agreement sales through August 28, 2026. Sales after that date are covered by Lind’s waiver of related adjustments.